Laryngopharyngeale Refluxerkrankung (LPRD) bei Kindern

Zusammenfassung

Zwischen 5 und 20 % aller Kinder leiden an einer gastroösophagealen Refluxerkrankung (GERD), die zu Erosionen, Ulzera und Metaplasien der Ösophagusschleimhaut führen kann. Überwindet der Mageninhalt in pathologischer Häufigkeit und Intensität auch den kindlichen oberen Ösophagussphinkter, liegt eine laryngopharyngeale Refluxerkrankung (LPRD) vor. Die mit einer kindlichen LPRD assoziierten Symptome und Folgeerkrankungen sind äußerst vielfältig.

Abstract

LPRD in children is characterized by symptoms, clinical findings, and sequelae caused by the reflux of gastric acid, bile acid or refluxate containing pepsin beyond the esophagus. For diagnostic procedures and therapy of gastroesophageal reflux disease (GERD) in children and adults widely accepted guidelines have been established. However, diagnosis and therapy of LPRD in children remains a continuous issue of inter- and intradisciplinary discussions. Although both GERD and LPRD in children are reflux-induced diseases, these two entities are different in symptoms, cause, diagnostic procedures, and therapy. Thus, the terms GERD and LPRD are not eligible to be used as synonyms.

Otorhinolaryngologists are becoming more and more involved in the management of children with suspicious LPRD. With flexible transnasal laryngopharyngoscopy being one of the most important diagnostic tools for LPRD detection, otorhinolaryngologists play an important role in the interdisciplinary diagnostic network of physicians treating children with suspected LPRD. The present article highlights age-dependent clinical symptoms, diagnostic tools, differential diagnoses, and adequate therapy for pediatric LPRD.

Schlüsselwörter

Hals-Nasen-Ohren-Heilkunde - Reflux - laryngopharyngeale Refluxerkrankung - Magensaft - Endoskopie - gastroösophageale Refluxerkrankung

Key words

Laryngopharyngeal reflux disease - Reflux - Otorhinolaryngology - endoscopy - gastroesophageal reflux disease

• Literatur

• 1 Zalzal GH, Tran LP. Pediatric gastroesophageal reflux and laryngopharyngeal reflux. Otolaryngol Clin North Am 2000; 33: 151-161
• 2 Ahrens P. Refluxerkrankungen bei Kindern - Diagnostik und Therapie. HNO 2012; 60: 206-215
• 3 Venkatesan NN, Pine HS, Underbrink M. Laryngopharyngeal reflux disease in children. Pediatr Clin North Am 2013; 60 (04) 865-878
• 4 Reichel O, Hagedorn H, Berghaus A. Diagnosis and treatment of laryngopharyngeal reflux. Laryngorhinootol 2006; 85: 919-928
• 5 Min HJ, Hong SC, Yang HS. et al Expression of CAIII and Hsp70 is increased in the mucous membrane oft he posterior commissure in laryngopharyngeal reflux disease. Yonsei Med J 2016; 57 (02) 469-474
• 6 May JG, Shah P, Lemonnier L. et al Systematic review of endoscopic airway findings in children with gastroesophageal reflux disease. Ann Otol Rhinol Laryngol 2011; 120 (02) 116-122
• 7 Block BB, Brodsky L. Hoarseness in children: the role of laryngopharyngeal reflux. Int J Pediatr Otorhinolaryngol 2007; 71: 1361-1369
• 8 Galluzzi F, Schindler A, Gaini RM. et al The assessment of children with suspected laryngopharyngeal reflux: an otorhinolaryngological perspective. Int J Pediatr Otorhinolaryngol 2015; 79: 1613-1619
• 9 Baudoin T, Kosec A, Cor I. et al Clinical features and diagnostic reliability in pediatric laryngopharyngeal reflux. Int J Pediatr Otorhinolaryngol 2014; 78 (07) 1101-1106
• 10 May JG, Shah P, Lemonnier L. et al Systematic Review of endoscopic airway findings in children with gastroesophageal reflux disease. Ann Otol Rhinol Laryngol 2011; 120 (02) 116-122
• 11 AWMF-Leitlinie der Dt. Gesellschaft für Kinderchirurgie(AWMF-Leitlinienregister Nr. 006/071). Gastro-ösophagealer Reflux bei Kindern(2015).
• 12 Mesallam TA. Oropharyngeal 24-hour pH-Monitoring in children with airway-related problems. Clin Exp Otorhinolaryngol 2016; 9 (02) 168-172
• 13 Van der Pol RJ, Smits MJ, van Wijk MP. et al Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics 2011; 127: 925-935
• 14 Bach KK, McGuirt Jr WF, Postma GN. Pediatric laryngopharyngeal reflux. Ear Nose Throat J 2002; 81 (09) (Suppl. 02) 27-31
• 15 Meyer TK, Olsen E, Merati A. Contemporary diagnostic and management techniques for extraoesophageal reflux disease. Curr Opin Otolaryngol Head Neck Surg 2004; 12 (06) 519-524
• 16 McGuirt Jr WF. Gastroesophageal reflux and the upper airway. Pediatr Clin North Am 2003; 50: 487-502
• 17 Czinn SJ, Blanchard S. Gastroesophageal reflux disease in neonates and infants. When and how to treat. Paediatr Drugs 2013; 15: 19-27
• 18 Guo H, Ma H, Wang J. Proton pump inhibitor therapy for the treatment of laryngopharyngeal reflux – a meta-analysis ofrandomized controlled trials. J Clin Gastroenterol 2016; 50: 295-300
• 19 McColl KEL, Gillen D. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. (Editorial) Gastroenterology 2009; 137: 20-22
• 20 McGlashan JA, Johnstone LM, Sykes J. et al The value of liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2009; 266: 243-251